Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model

Bone

Volumn 42, Issue 5, 2008, Pages 921-931

  Virk, Mandeep Singh ^a   Conduah, Augustine ^b   Park, Sang Hyun ^c   Liu, Nancy ^b   Sugiyama, Osamu ^a   Cuomo, Anna ^b   Kang, Christine ^b   Lieberman, Jay R ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOINT REPLACEMENT INSTITUTE   (United States)

Author keywords

Adenoviral vector; Bioluminescent imaging; Bone morphogenetic protein; Bone repair; Ex vivo regional gene therapy; Lentiviral vector

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; LENTIVIRUS VECTOR; LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BIOMECHANICS; BONE MARROW CELL; BONE REMODELING; CONTROLLED STUDY; DRUG EFFICACY; FEMUR MALFORMATION; FRACTURE HEALING; IN VITRO STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; QUALITY CONTROL; RAT; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; BIOMECHANICS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; BONE MORPHOGENETIC PROTEINS; ELASTICITY; FEMORAL FRACTURES; FRACTURE HEALING; GENE THERAPY; GENETIC VECTORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LENTIVIRUS; LUCIFERASES; LUMINESCENT MEASUREMENTS; MALE; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 41949123855     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.12.216     Document Type: Article

References (51)

1. Nocini PF, Bedogni A, Valsecchi S, Trevisiol L, Ferrari F, Fior A, Saia G. Fractures of the iliac crest following anterior and posterior bone graft harvesting. Review of the literature and case presentation. Minerva Stomatol 2003;52: 441-448, 448-52.
2. Boone D.W. Complications of iliac crest graft and bone grafting alternatives in foot and ankle surgery. Foot Ankle Clin 8 (2003) 1-14
3. Gamradt S.C., and Lieberman J.R. Bone graft for revision hip arthroplasty: biology and future applications. Clin Orthop Relat Res (2003) 183-194
4. Lieberman J.R., Daluiski A., and Einhorn T.A. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Jt Surg Am 84-A (2002) 1032-1044
5. Seeherman H.J., Azari K., Bidic S., Rogers L., Li X.J., Hollinger J.O., et al. rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii. J Bone Jt Surg Am 88 (2006) 1553-1565
6. Lawrence J.P., Waked W., Gillon T.J., White A.P., Spock C.R., Biswas D., et al. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model. Spine 32 (2007) 1206-1213
7. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., and Rueger D.C. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop Relat Res (1994) 302-312
8. Boden S.D., Martin Jr. G.J., Horton W.C., Truss T.L., and Sandhu H.S. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J Spinal Disord 11 (1998) 95-101
9. Maniscalco P., Gambera D., Bertone C., Rivera F., Crainz E., and Urgelli S. Healing of fresh tibial fractures with OP-1. A preliminary report. Acta Biomed 73 (2002) 27-33
10. Ristiniemi J., Flinkkila T., Hyvonen P., Lakovaara M., Pakarinen H., and Jalovaara P. RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation. J Bone Jt Surg Br 89 (2007) 265-272
11. Jones A.L., Bucholz R.W., Bosse M.J., Mirza S.K., Lyon T.R., Webb L.X., et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Jt Surg Am 88 (2006) 1431-1441
12. Vaccaro A.R., Whang P.G., Patel T., Phillips F.M., Anderson D.G., Albert T.J., et al. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J (2007)
13. Vaibhav B., Nilesh P., Vikram S., and Anshul C. Bone morphogenic protein and its application in trauma cases: A current concept update. Injury (2007)
14. Bridwell K.H., Anderson P.A., Boden S.D., Vaccaro A.R., and Wang J.C. What's new in spine surgery. J Bone Jt Surg Am 87 (2005) 1892-1901
15. Swiontkowski M.F., Aro H.T., Donell S., Esterhai J.L., Goulet J., Jones A., et al. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Jt Surg Am 88 (2006) 1258-1265
16. Martin Jr. G.J., Boden S.D., Marone M.A., Marone M.A., and Moskovitz P.A. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. J Spinal Disord 12 (1999) 179-186
17. Boden S.D. Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine 26 (2001) 850
18. Baltzer A.W., and Lieberman J.R. Regional gene therapy to enhance bone repair. Gene Ther 11 (2004) 344-350
19. Lieberman J.R. Orthopaedic gene therapy. Fracture healing and other nongenetic problems of bone. Clin Orthop Relat Res (2000) S156-S158
20. Lieberman J.R., Ghivizzani S.C., and Evans C.H. Gene transfer approaches to the healing of bone and cartilage. Mol Ther 6 (2002) 141-147
21. Gamradt S.C., and Lieberman J.R. Genetic modification of stem cells to enhance bone repair. Ann Biomed Eng 32 (2004) 136-147
22. Hannallah D., Peterson B., Lieberman J.R., Fu F.H., and Huard J. Gene therapy in orthopaedic surgery. Instr Course Lect 52 (2003) 753-768
23. Feeley B.T., Conduah A.H., Sugiyama O., Krenek L., Chen I.S., and Lieberman J.R. In vivo molecular imaging of adenoviral versus lentiviral gene therapy in two bone formation models. J Orthop Res 24 (2006) 1709-1721
24. Egermann M., Lill C.A., Griesbeck K., Evans C.H., Robbins P.D., Schneider E., et al. Effect of BMP-2 gene transfer on bone healing in sheep. Gene Ther 13 (2006) 1290-1299
25. Xu X.L., Tang T., Dai K., Zhu Z., Guo X.E., Yu C., et al. Immune response and effect of adenovirus-mediated human BMP-2 gene transfer on the repair of segmental tibial bone defects in goats. Acta Orthop 76 (2005) 637-646
26. Lieberman J.R., Daluiski A., Stevenson S., Wu L., McAllister P., Lee Y.P., et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Jt Surg Am 81 (1999) 905-917
27. Betz O.B., Betz V.M., Nazarian A., Pilapil C.G., Vrahas M.S., Bouxsein M.L., et al. Direct percutaneous gene delivery to enhance healing of segmental bone defects. J Bone Jt Surg Am 88 (2006) 355-365
28. Southwood L.L., Frisbie D.D., Kawcak C.E., Ghivizzani S.C., Evans C.H., and McIlwraith C.W. Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model. J Orthop Res 22 (2004) 66-72
29. Wang J.C., Kanim L.E., Yoo S., Campbell P.A., Berk A.J., and Lieberman J.R. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Jt Surg Am 85-A (2003) 905-911
30. Park J., Ries J., Gelse K., Kloss F., von der Mark K., Wiltfang J., et al. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther 10 (2003) 1089-1098
31. Riew K.D., Lou J., Wright N.M., Cheng S.L., Bae K.T., and Avioli L.V. Thoracoscopic intradiscal spine fusion using a minimally invasive gene-therapy technique. J Bone Jt Surg Am 85-A (2003) 866-871
32. Musgrave D.S., Bosch P., Ghivizzani S., Robbins P.D., Evans C.H., and Huard J. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 24 (1999) 541-547
33. Egermann M., Baltzer A.W., Adamaszek S., Evans C., Robbins P., Schneider E., et al. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum Gene Ther 17 (2006) 507-517
34. Peterson B., Iglesias R., Zhang J., Wang J.C., and Lieberman J.R. Genetically modified human derived bone marrow cells for posterolateral lumbar spine fusion in athymic rats: beyond conventional autologous bone grafting. Spine 30 (2005) 283-289 [discussion 289-90]
35. Hsu W.K., Sugiyama O., Park S.H., Conduah A., Feeley B.T., Liu N.Q., et al. Lentiviral-mediated BMP-2 gene transfer enhances healing of segmental femoral defects in rats. Bone 40 (2007) 931-938
36. Sugiyama O., An D.S., Kung S.P., Feeley B.T., Gamradt S., Liu N.Q., et al. Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther 11 (2005) 390-398
37. Deroose C.M., Reumers V., Gijsbers R., Bormans G., Debyser Z., Mortelmans L., et al. Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imaging. Mol Ther 14 (2006) 423-431
38. Bonci D., Cittadini A., Latronico M.V., Borello U., Aycock J.K., Drusco A., et al. "Advanced" generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther 10 (2003) 630-636
39. Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38 (2006) 1424-1429
40. Ray S., Paulmurugan R., Hildebrandt I., Iyer M., Wu L., Carey M., et al. Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression. Hum Gene Ther 15 (2004) 681-690
41. Iyer M., Wu L., Carey M., Wang Y., Smallwood A., and Gambhir S.S. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci U S A 98 (2001) 14595-14600
42. Manilla P., Rebello T., Afable C., Lu X., Slepushkin V., Humeau L.M., et al. Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 16 (2005) 17-25
43. Flaitz C.M., and Hicks M.J. Molecular piracy: the viral link to carcinogenesis. Oral Oncol 34 (1998) 448-453
44. Zufferey R. Production of lentiviral vectors. Curr Top Microbiol Immunol 261 (2002) 107-121
45. Zufferey R., Dull T., Mandel R.J., Bukovsky A., Quiroz D., Naldini L., et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72 (1998) 9873-9880
46. Dull T., Zufferey R., Kelly M., Mandel R.J., Nguyen M., Trono D., et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 72 (1998) 8463-8471
47. Bai Y., Soda Y., Izawa K., Tanabe T., Kang X., Tojo A., et al. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector. Gene Ther 10 (2003) 1446-1457
48. Deglon N., Tseng J.L., Bensadoun J.C., Zurn A.D., Arsenijevic Y., Pereira de Almeida L., et al. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum Gene Ther 11 (2000) 179-190
49. Gafni Y., Pelled G., Zilberman Y., Turgeman G., Apparailly F., Yotvat H., et al. Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 9 (2004) 587-595
50. Koefoed M., Ito H., Gromov K., Reynolds D.G., Awad H.A., Rubery P.T., et al. Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther 12 (2005) 212-218
51. Ulrich-Vinther M. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Acta Orthop Suppl 78 (2007) 1-64